Media

Relevant Literature

  1. Spiegelman, B.M. (2013) Banting Lecture 2012: Regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes, 62, 1774-1782.
  2. Lidell, M.E., Betz, M.J. and Enerback, S. (2014) Brown adipose tissue and its therapeutic potential. J Intern Med, 276, 364-377.
  3. Steinberg, G.R. (2018) Cellular Energy Sensing and Metabolism-Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture. Diabetes, 67, 169-179.
  4. Herz, C.T. and Kiefer, F.W. (2019) Adipose tissue browning in mice and humans. J Endocrinol, 241, R97-R109.
  5. Lee, P., Swarbrick, M.M. and Ho, K.K. (2013) Brown adipose tissue in adult humans: a metabolic renaissance. Endocr Rev, 34, 413-438.
  6. Kaisanlahti, A. and Glumoff, T. (2019) Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes. J Physiol Biochem, 75, 1-10.
  7. Yoneshiro, T. and Saito, M. (2015) Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans. Ann Med, 47, 133-141.
  8. Lee, M.W., Lee, M. and Oh, K.J. (2019) Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs. J Clin Med, 8.
  9. Zhang, B., Yang, Y., Xiang, L., Zhao, Z. and Ye, R. (2019) Adipose-derived exosomes: A novel adipokine in obesity-associated diabetes. J Cell Physiol.
  10. Hanna, J., Hossain, G.S. and Kocerha, J. (2019) The Potential for microRNA Therapeutics and Clinical Research. Front Genet, 10, 478.
  11. Ying, W., Riopel, M., Bandyopadhyay, G., Dong, Y., Birmingham, A., Seo, J.B., Ofrecio, J.M., Wollam, J., Hernandez-Carretero, A., Fu, W. et al. (2017) Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity. Cell, 171, 372-384 e312.
  12. Pan, Y., Hui, X., Hoo, R.L.C., Ye, D., Chan, C.Y.C., Feng, T., Wang, Y., Lam, K.S.L. and Xu, A. (2019) Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation. J Clin Invest, 129, 834-849.
  13. Li, Z. and Rana, T.M. (2014) Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov, 13, 622-638.
  14. Smith CIE, Zain R. Therapeutic Oligonucleotides: State of the Art. Annu Rev Pharmacol Toxicol. 2019;59:605-630.
  15. Hanna J, Hossain GS, Kocerha J. The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019;10:478.
  16. S. T. Crooke, X. H. Liang, B. F. Baker and R. M. Crooke. J Biol Chem. 2021 Feb 15:100416. doi: 10.1016/j.jbc.2021.100416.
  17. Crooke, S. T., Baker, B. F., Crooke, R. M., Liang, X. H. Antisense technology: an overview and prospectus. Nat Rev Drug Discov. 2021; Mar 24. pii: 10.1038/s41573-021-00162-z. doi: 10.1038/s41573-021-00162-z.